644 filings
Page 19 of 33
4
rwz7hhtt9t
13 Mar 20
AzurRx BioPharma / Vern Lee Schramm ownership change
4:10pm
4
dmn7z19qb
13 Mar 20
AzurRx BioPharma / EDWARD BORKOWSKI ownership change
4:10pm
8-K
22r5x9u
2 Mar 20
CIR offers significant source of support for on-going MS1819 Phase 2 clinical studies in Europe
4:57pm
SC 13G/A
zfpk8nwg 550eh
14 Feb 20
Beneficial ownership report (amended)
9:00am
SC 13D/A
kxzspzaw3rby4s8
29 Jan 20
Beneficial ownership report (amended)
2:03pm
4
scq9 h8pc03vn
29 Jan 20
AzurRx BioPharma / Edmund Burke Jr. Ross ownership change
2:01pm
8-K
fusmeq2 nsmhdt9j
22 Jan 20
Other Events
10:20am
424B3
p41lqs16yq
17 Jan 20
Prospectus supplement
5:21pm
D
41e9v2lb245b mo1d9m
17 Jan 20
$8M in debt / options, sold $6.9M, 70 investors
4:56pm
EFFECT
kkrx6owor8 6e6d
15 Jan 20
Notice of effectiveness
12:15am
8-K
5hdr m1qz9txylmr
14 Jan 20
AzurRx BioPharma Announces Closing of $6.9 Million Private Placement Email
12:00am
8-K
mav nn1m3g8nac4
13 Jan 20
Other Events
12:00am
CORRESP
6f5cq
13 Jan 20
Correspondence with SEC
12:00am
4
zw0tu1
9 Jan 20
AzurRx BioPharma / Daniel H Schneiderman ownership change
4:10pm
3
h6qwk
9 Jan 20
AzurRx BioPharma / Daniel H Schneiderman ownership change
4:05pm
UPLOAD
5pd0 47zfst
7 Jan 20
Letter from SEC
12:00am
8-K
61ukjz3x1qy1a07r2zuc
6 Jan 20
AzurRx BioPharma Announces Appointment of Daniel Schneiderman as Chief Financial Officer
4:12pm